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Abstract
Over the past three decades various definitions 
of cancer survivor and cancer survivorship have 
been proposed. These definitions frequently 
describe (1) who is considered a cancer survivor 
and who is experiencing cancer survivorship, 
(2) what it means to a be survivor and 
experience survivorship, and (3) when someone 
is considered a survivor and when survivorship 
begins. Descriptive epidemiology indicates that 
certain individuals diagnosed and treated for 
cancer describe the presence of specific unmet 
needs following diagnosis and treatment for 
cancer. Evidence also points to an increased 
likelihood of cancer recurrence or a new cancer 
in many cancer patients. These observations 
should be reflected in the case definitions of 
cancer survivor and cancer survivorship. This 
paper reviews the literature for evidence to 
validate existing definitions of cancer survivor 
and cancer survivorship and proposes updated 
definitions for each. Based on this evidence, 
a cancer survivor is defined as an individual 
diagnosed with cancer. The period following 
primary treatment, which is characterized by 
transitions in care and a need to address the 
late effects of cancer and its treatment, may 
be a particularly critical time for the cancer 
survivor. The definition does not preclude the 
major involvement of family, friends, caregivers, 
and providers, but does place the focus on 
the individual who received the diagnosis 
Resumen
Durante las últimas tres décadas se han 
propuesto diversas definiciones del supervi-
viente de cáncer y la supervivencia del cáncer. 
Estas definiciones describen con frecuencia (1) 
quién se considera un superviviente de cán-
cer y quién experimenta la supervivencia del 
cáncer, (2) lo que significa ser superviviente 
y la experiencia de sobrevivir, y (3) cuándo 
se considera que alguien es un superviviente 
y cuándo comienza a ser un superviviente. La 
epidemiología descriptiva indica que ciertos 
individuos diagnosticados y tratados de cáncer 
describen la presencia de necesidades especí-
ficas insatisfechas tras el diagnóstico y trata-
miento para el cáncer. Los datos disponibles. 
apuntan a un aumento de la probabilidad de 
recurrencia del cáncer o un nuevo cáncer en 
muchos pacientes con cáncer. Estas observacio-
nes deben reflejarse en las definiciones de caso 
del superviviente de cáncer y la supervivencia 
del cáncer. Este artículo revisa los datos rela-
tivos a la validez de las definiciones existentes 
de superviviente de cáncer y supervivencia del 
cáncer y propone definiciones actualizadas 
para cada uno. Con base en estos hallazgos, 
se define como superviviente de cáncer a un 
individuo diagnosticado con cáncer. El periodo 
que sigue al tratamiento primario, que se ca-
racteriza por las transiciones en el cuidado y 
la necesidad de abordar los efectos tardíos del 
cáncer y su tratamiento, puede ser un momen-
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of cancer. Children and young adult cancer 
survivors should be housed in subgroups under 
the “cancer survivor” umbrella. In addition, 
cancer survivorship is defined as the period 
of time beginning at cancer diagnosis where 
attention by the survivor and his or her care 
team is directed at addressing needs related 
to health, symptoms, function, lifestyle, and 
well-being; these needs may change through 
the care trajectory. Coordination of care 
between oncologist specialists involved in the 
early phases of cancer diagnosis and treatment 
and primary care physicians involved in long-
term follow-up is critical. As new knowledge 
is acquired regarding cancer survival and the 
cancer experience, modifications to these 
proposed definitions will be imperative. 
Keywords: Cancer, oncology, cancer 
survivor, cancer survivors, cancer survivorship, 
definition, definitions.
to especialmente crítico para el superviviente 
de cáncer. La definición no excluye la impor-
tante participación de la familia, amigos, cui-
dadores y proveedores, pero pone el foco en la 
persona que recibió el diagnóstico de cáncer. 
Los niños y los jóvenes adultos supervivientes 
de cáncer deben ser ubicados en subgrupos 
bajo el paraguas de “superviviente de cáncer”. 
Además, definimos la supervivencia del cáncer 
como el período de tiempo que comienza en 
el diagnóstico del cáncer en el que la atención 
del equipo de cuidados para el superviviente se 
centra en las necesidades relativas a la salud, 
la funcionalidad, los síntomas, el estilo de vida 
y bienestar; estas necesidades pueden cambiar 
a través de la trayectoria del cuidado. Es fun-
damental la coordinación de la atención entre 
los especialistas oncólogos, que participan en 
las primeras fases de diagnóstico y tratamiento 
del cáncer, y los médicos de atención primaria 
involucrados en el seguimiento a largo plazo 
de la enfermedad. Las modificaciones a las 
definiciones propuestas se harán necesarias a 
medida que se adquieran nuevos conocimien-
tos en relación a la supervivencia del cáncer y 
la experiencia del cáncer. 
Palabras clave: Cáncer, oncología, super-
viviente de cáncer, supervivientes de cáncer, 
supervivencia al cáncer, definiciones.
OVERVIEW
While the incidence of cancer continues 
to increase, improvements in detection, di-
agnosis, and treatment(1) have led to steady 
declines in mortality over the past four de-
cades(2). Internationally, an estimated 32.6 
million cancer survivors were living within 
five years of diagnosis in 2012(2). This sta-
tistic is based exclusively on a definition of 
cancer survivor that only considers 5-year 
prevalent cancer cases. However, other 
definitions of “cancer survivor” have been 
considered over the past several decades(3). 
There is also a lack of consensus surround-
ing the definition of “cancer survivorship,” 
a term often used in tandem with “cancer 
survivor.” Though authors of recent reviews 
have provided excellent summaries on key 
concepts related to cancer survivors and 
cancer survivorship(3,4), they have not clear-
ly proposed updated definitions of cancer 
survivor and cancer survivorship based on 
the literature. In order to move forward in 
our understanding and ability to determine 
meaningful intervention targets and out-
comes for cancer survivorship care, global 
consensus should be reached regarding ev-
idence-based definitions of cancer survivor 
and cancer survivorship. As the definitions 
will guide resource allocation, it will be 
important that they capture the subset of 
individuals most affected by cancer and its 
treatment. 
Tables 1 and 2 provide the range of 
definitions for cancer survivor and cancer 
survivorship that have been proposed over 
the last three decades. These definitions 
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seek to answer the following common 
questions: (1) Who is a cancer survivor and 
who is included in the cancer survivorship 
experience?; (2) What does it mean to be a 
survivor and experience survivorship?; and 
(3) When is someone considered a survivor 
and when does survivorship begin? This 
paper will provide a literature review of 
evidence related to each of these questions 
and propose updated definitions for cancer 
survivor and cancer survivorship based on 
these findings. 
Who is a cancer survivor and who is 
included in the cancer survivorship 
experience?
The scope of the population included 
as cancer survivors and those experienc-
ing cancer survivorship has implications 
for who should be included in cancer 
survivorship care, and, by extension, who 
should be targeted for cancer survivorship 
research. Definitions of cancer survivorship 
such as that from the National Cancer In-
Table 1. Cancer Survivor: Definitions
Source Term Defined Definition
Historical Definition (Leigh, 
1996)(5)
Cancer Survivor Family members who survived the loss of 
a loved one to cancer.
Centers for Disease Control and 
Prevention (Division of Cancer 
Prevention and Control, 2014)(6)
Cancer Survivor Anyone who has been diagnosed with 
cancer, from the time of diagnosis through 
the balance of his or her life.
Biomedical Definition (Leigh, 
1996; Marcus, 2004; Rowland, 
2007; Twombly, 2004)(5,7-9)
Survivor Individuals who have had a life-
threatening disease but have remained 
disease free for a minimum of 5 years.
World Health Organization 
(World Health Organization, 
2008)(10)
Cancer Survivors Those patients who having had cancer, 
are, following treatment, now cured 
of the disease. Cure is defined as the 
attainment of normal life expectancy 
and has three important components: 
(1) recovery from all evidence of disease 
(complete remission); (2) attainment of a 
stage of minimal or no risk of recurrence 
or relapse; (3) restoration of functional 
health (physical, developmental, and 
psychosocial).
Journal of Cancer Survivorship 
(Feuerstein, 2007)(11)
Cancer Survivors Populations and individuals with a 
diagnosis of cancer who have completed 
primary treatment or the major aspects 
of treatment for cancer. Survivors may 
be continuing with “treatment” or 
management such that it is unclear when 
primary treatment has ended. Survivors 
will also have a desire or need to “get on 
with their lives.” Survivors are considered 
individuals with the cancer diagnosis, not 
the family. 
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stitute (NCI)(15), include “family members, 
friends, and caregivers” (See Table 2). A 
recent definition by NCI of cancer survi-
vorship research directs efforts to the indi-
vidual who received the cancer diagnosis 
and treatment. NCI proposes that research 
in the area of cancer survivorship “focus 
on the health and life of a person with 
a history of cancer beyond the acute di-
agnosis and treatment phase”(16) and does 
not mention family members, friends, or 
caregivers (See Table 2). 
However, there is evidence to suggest 
that psychosocial interventions including 
family members or caregivers are more ef-
ficacious than interventions focusing solely 
on patients with chronic illness(18). The pa-
tients in these interventions are not unlike 
cancer patients, who are increasingly being 
conceptualized as having a chronic illness. 
A meta-analysis of randomized trials com-
pared usual medical care to chronic illness 
psychosocial interventions targeting either 
a patient’s closest family member or both 
the patient and the family member(19). The 
authors found that including a spouse in in-
terventions decreased depression and mor-
tality in patients, and caregiving burden, de-
pression and anxiety in family members(19). 
Family interventions have shown promise 
specifically in cancer patients in reducing 
patient feelings of hopelessness and nega-
tive appraisal of illness, as well as reducing 
negative appraisal of caregiving(20). 
While family members, friends, and 
caregivers may impact a cancer survivor’s 
experience in terms of symptom burden 
and outcomes, other parties, such as cli-
nicians, may do the same. The type and 
quality of clinicians serving cancer patients 
has been found to influence important as-
pects of survivorship including satisfaction, 
symptom control, inpatient hospital days, 
cost, and pain severity(21,22). The NCI defini-
tion of cancer survivorship acknowledges 
the impact of clinicians by stating that can-
cer survivorship “includes issues related to 
the ability to get health care and follow-up 
treatment”(15), yet clinicians are not specifi-
cally included in the definition of cancer 
survivorship. Thus, whether or not a given 
party is “part of the survivorship experi-
ence” may not be sufficient to include that 
party in the definitions of cancer survivor 
and cancer survivorship. Rather, whether 
or not a given party (in this case, family, 
friends, or caregivers) shares the same ex-
perience as the cancer survivor should ul-
timately guide the appropriateness of their 
inclusion in definitions of cancer survivor 
and cancer survivorship. 
At a basic level, it is not hard to argue 
that family members, friends, and caregiv-
ers are exempt from the numerous medical 
treatments and tests that cancer survivors 
often undergo. Further, while the experi-
ence of family, friends, and caregivers in-
cludes the threat of loss, the experience 
of cancer survivors includes the more per-
sonal threat of death. When it comes to 
subjective illness experiences, caregivers 
and cancer patients have different percep-
tions of psychological symptoms(23), mar-
riage quality, and aspects of patient func-
tioning (e.g. depression, fear of the future, 
and confidence in treatment(24). Compared 
to their caregiver’s report, patients would 
view their functioning more positively and 
their marital quality more negatively(24). 
Consequently, it seems reasonable to con-
clude that the experience of cancer sur-
vivorship is exclusive and unique to the 
cancer patient, who alone can be con-
sidered a cancer survivor. Clinicians and 
researchers should not, however, dismiss 
the important role that family members, 
friends, and caregivers can play in a cancer 
patient’s experience as well as the unique 
challenges they face as a consequence of 
having a loved one battle cancer. 
Additional debate involves whether 
both adults and children should be in-
cluded in a universal definition of cancer 
survivor. There is a paucity of literature di-
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rectly comparing the experiences of child-
hood cancer survivors to adult cancer sur-
vivors. One study found that significantly 
more adult, but not child, cancer survivors 
scored in the clinical range for depression 
(29% vs. 18%, respectively) and somatic 
problems (23% vs. 12% respectively)(25). 
No significant correlation was found be-
tween time elapsed from cancer diagnosis 
to completion of the questionnaires with 
any of the psychosocial measures(25). With 
childhood survivors constituting a minority 
0.5% to 3.0% of the total survivor popula-
tion(26,27), this subgroup could arguably still 
be considered a part of “cancer survivors,” 
even if they experience a different set of 
challenges from adult cancer survivors. 
Nevertheless, it should be noted that 
separate survivorship guidelines have been 
developed for the care of childhood cancer 
survivors(28) and adult cancer survivors(17). 
While both children and adults who re-
ceive a cancer diagnosis and experience 
long term and late effects of diagnosis and 
treatment can be considered cancer sur-
vivors, both groups are frequently treated 
as distinct subgroups, often with unique 
survivorship needs. Future research should 
explore the similarities and differences 
among children, young adult, and adult 
cancer survivors in order to clarify which 
problems and associated interventions may 
be generalizable and which may require 
adaptations. This paper will only focus on 
adult and young adult cancer survivors and 
survivorship. The U.S. adult cancer survi-
vor population consists of individuals aged 
15 years and older(29), which includes the 
subset of adolescents and young adult can-
cer survivors ranging from 15 to 39 years 
at diagnosis(30). 
What does it mean to be a survivor and 
experience survivorship?
Cancer survivors report being in good 
health, having a good to excellent quality 
of life(31,32), and not suffering from psycho-
logical morbidity or experiencing a large 
number of unmet supportive care needs(33). 
However, a proportion of those living after 
diagnosis and primary treatment do con-
tinue to experience the burden of physical 
and psychosocial health problems related 
to cancer and its treatment(34). A popula-
tion-based study comparing individuals 
who completed primary treatment for can-
cer to individuals with non-cancer chronic 
illnesses and healthy controls observed 
that those with cancer experienced the 
poorest health on all indicators studied(35). 
This study clearly indicates that individu-
als following diagnosis and treatment for 
cancer report a number of problem areas 
that differ from what has been observed in 
other chronic illnesses. A review of long-
term and late effects of a range of treat-
ment exposures in individuals following 
cancer treatment reported that these prob-
lems may last for more than 10 years(36).
A definition of cancer survivor provided 
by the World Health Organization (WHO) 
(See Table 1)(10) assumes that individuals 
are cancer survivors if they meet the fol-
lowing three criteria: 1) “recovery from all 
evidence of disease,” 2) “attainment of a 
stage of minimal or no risk of recurrence or 
relapse,” and 3) “restoration of functional 
health (physical, developmental, and psy-
chosocial”(10). These criteria may be better 
viewed as suitable and well-intentioned 
goals, given the aforementioned evidence 
pointing to frequent and persistent second-
ary health and functional effects long after 
an individual’s cancer diagnosis and treat-
ment. 
A major concern with the cancer sur-
vivor definition from WHO and similar 
definitions(12) is their inconsistency with 
the evidence that many post-treatment 
cancer patients continue to carry a signifi-
cant risk of recurrence or relapse for the 
remainder of their lives(37). This risk varies 
depending on the type of initial primary 
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cancer diagnosed, treatment received, and 
age at diagnosis(38,39). The American Can-
cer Society (ACS) found that following pri-
mary treatment for cancer, patients of all 
cancer diagnoses have a 15% lifetime risk 
of developing a second primary cancer(38). 
Survivors of certain cancers face a consid-
erable threat of recurrence. In bladder can-
cer patients, for instance, the rate of recur-
rence, ranges from 15-61% within 1 year 
and from 31-78% within 5 years(40). In one 
of the most common cancers(38), colorectal 
cancer (CRC), recurrence ranges from 12% 
within 5 years for stage I patients(41) to 40% 
for stage II or III patients(42). In 20% of fe-
male breast cancer cases, local, regional or 
distant recurrence occurs within 10 years 
after cancer diagnosis(42). For prostate can-
cer, an average of 15% of patients experi-
ence recurrence within 5 years of radical 
prostatectomy(44).
Even within patients of a single cancer 
type, survival and recurrence has great vari-
ation. Also, limiting the case definition of 
a cancer survivor and the period of cancer 
survivorship to only those individuals with 
minimal or no risk of recurrence or relapse 
requires valid models for prognostic scor-
ing to predict recurrence. In some cancers, 
such as gastric cancer, models have been 
developed with high levels of sensitivity 
and specificity in predicting recurrence(45). 
However, in many other cancers, predict-
ing prognosis remains clinically challeng-
ing(46-49). Even when risk prediction models 
exist, communicating survival probabilities 
to patients is often laden with difficulties 
(e.g., reports are too difficult for patients 
to understand, graphs are overly techni-
cal, and recurrence probabilities with and 
without therapy can divert patients from 
considering adverse effects a part of the 
trade-off), and may backfire or cause con-
fusion(50) . Given that both secondary health 
and functional problems and a risk of re-
currence can often occur among individu-
als following diagnosis and primary cancer 
treatment, it follows that the definitions of 
cancer survivor and cancer survivorship 
should avoid excluding individuals on the 
basis of susceptibility to these experiences. 
When is someone considered a survivor 
and when does survivorship begin?
The classic definition of cancer survi-
vorship was first proposed by Dr. Fitzhugh 
Mullan three decades ago(14). This defini-
tion, which includes three “seasons of 
survival” (See Table 2), considers cancer 
patients to be survivors from the time of 
diagnosis. Post-diagnosis, Mullan argued, 
was the time when cancer patients natu-
rally fell into the category of “survivor” by 
being frequently confronted with their own 
mortality and needing to make changes 
that could impact their future.
Cancer patients experience unique 
concerns related to their cancer at each 
stage of the care trajectory. At diagno-
sis, some may face an “existential crisis”; 
when primary treatment has ended, indi-
viduals may experience other long-term 
concerns (e.g., health, receipt of quality 
health care following treatment, functional 
changes, lifestyle changes)(51). Ability to 
work also changes throughout the trajec-
tory, with the majority of cancer patients 
who worked before their diagnosis being 
able to return following treatment(4,51). At 
all of these points, cancer patients need to 
“survive” and “thrive” through each of the 
(often changing) issues confronting them. 
As such, the proposed definitions of 
cancer survivor and cancer survivorship 
should include individuals immediately 
following a cancer diagnosis. Consistent 
with several existing definitions(6,13-17), 
the view that survivorship begins from 
the moment of diagnosis is becoming in-
creasingly prevalent(51). By contrast, sev-
eral definitions of cancer survivor and sur-
vivorship require completion of primary 
treatment, which may vary across cancer 
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types and, in some cases, be difficult to 
define. As diagnosis is a universal concept 
across cancer survivors, it is a time point 
that naturally yields itself to universal 
definitions of cancer survivor and cancer 
survivorship. 
Proposing that survivorship begins at 
diagnosis does not preclude the empha-
sis that should be placed on the period 
following cancer treatment. Despite prob-
lems regularly faced by cancer patients 
following treatment(35), they often tran-
sition into a phase including isolation 
and less involvement from their medical 
team(4). Among patients (30%) who re-
port five or more unmet needs at the end 
of treatment, 60% said that those needs 
were still unmet at six months(52). This may 
point to a need for more care in the post-
treatment stage. 
However, a lack of care is routinely 
due to a lack of clarity among patients, 
oncologists, and primary care physicians 
(PCPs) about who is responsible for provid-
ing care for long-term cancer survivors(53). 
A survey of oncologists, who typically are 
most involved during diagnosis and treat-
ment, and PCPs, who are often most in-
volved in follow-up care, found that both 
expected to be significantly involved in 
cancer survivorship care(53). Defining sur-
vivorship as beginning at diagnosis un-
derscores the importance of a shared re-
sponsibility among early treatment-stage 
clinicians and follow-up stage clinicians 
in addressing survivorship issues. It is also 
consistent with the Institute of Medicine’s 
four essential components of survivorship 
care: prevention, surveillance, interven-
tion, and coordination(51). Continued care 
by both oncologist specialists and PCPs re-
sults in patients receiving more follow-up 
cancer and noncancer preventive services 
than care by an oncologist specialist or 
PCP alone(54). Improved communication 
about long-term care expectations from 
clinicians during treatment may aid in pre-
venting misunderstandings among cancer 
patients and help them to better navigate 
the health care system during follow-up. 
Multidisciplinary and integrated clinics(4) 
are two models of survivorship care which 
may help to create a sense of shared re-
sponsibility for the cancer survivor and im-
prove access to clinicians best equipped 
to address the changing needs of cancer 
patients through the different stages of sur-
vivorship. 
PROPOSED WORKING DEFINITIONS
Cancer survivor
A cancer survivor is any individual 
who is living and diagnosed with some 
type of cancer. By extension, cancer sur-
vivors are populations of individuals diag-
nosed and living with any type of cancer. 
Cancer survivors are individuals who pos-
sess the unique direct experience of going 
through cancer, and not their family mem-
bers, friends, or caregivers. The identity of 
“cancer survivor” is maintained from diag-
nosis, through treatment, post-treatment, 
and for the remainder of the individual’s 
life. The “cancer survivor” identity may be 
particularly salient after individuals have 
completed primary cancer treatment or - 
recognizing that for some individuals, this 
stage will not have a clear ending - the 
major aspects of cancer treatment. The 
definition is not contingent on the cancer 
being cured. It does not assume that ab-
sence of disease is necessary or sufficient. 
Children and young adult cancer survivors 
should be housed in subgroups under the 
“cancer survivor” umbrella. As Table 1 in-
dicates, this case definition is more restric-
tive than earlier definitions that included 
members of the family or friends, but it is 
more inclusive in terms of not requiring 
“cure” or a particular time period to have 
passed in order to be considered a cancer 
survivor. 
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Cancer survivorship
Cancer survivorship is the period of time 
beginning at cancer diagnosis and span-
ning through treatment, post-treatment, 
and the remainder of the individual’s life. 
The period following major primary treat-
ments may be of particular salience to can-
cer survivorship efforts and care as residual 
long-term or late effects of the cancer and 
its treatment begin to dominate a cancer 
patient’s experience while health care utili-
zation tends to decrease. The late and long-
term effects relevant to cancer survivorship 
can be broadly categorized into medical ef-
fects, symptom burden, functional changes, 
and well-being. As can be seen in Table 
2, this definition encompasses acute, ex-
tended, and permanent phases of survivor-
ship as Mullan proposed. This definition 
is also consistent with that proposed by 
LiveStrong which includes individuals liv-
ing “with, through, and beyond cancer.” 
Unique to this definition is an emphasis on 
the relevance of the post-primary treatment 
period to cancer survivorship initiatives. 
Going forward: How should we use these 
definitions? 
Having proposed definitions for can-
cer survivor and cancer survivorship, it 
is important to consider when the use of 
these definitions is appropriate. While they 
should be used to help aid decision making 
in research and practice, caution should 
be exercised when referring to these terms 
with patients. Survivorship is being in-
creasingly viewed as an important topic 
for research and health care in Europe, but 
a stigma towards the term “cancer survi-
vor” may still persist(51). Going forward, 
as knowledge on cancer survival and the 
cancer patient’s experience across the care 
trajectory increases, it will be important to 
revisit these definitions and modify them 
based on the latest evidence. 
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